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The carnitine transporter was solubilized from rat liver microsomes with Triton X-100 and reconstituted into liposomes, after addition of Triton X-
114, by removing the detergent from mixed micelles by hydrophobic chromatography on Amberlite (Bio-Beads SM 2). The reconstitution was
optimized with respect to the detergent/phospholipid ratio, the protein concentration, and the number of passages through a single Amberlite column.
The reconstituted carnitine transporter catalyzed a first-order uniport reaction inhibited by HgCl2 and DIDS. The IC50 for HgCl2 was 0.16±0.03mM.
The reconstituted transporter also catalyzed carnitine efflux from the proteoliposomes; the efflux was stimulated by externally added long-chain
acylcarnitines. Besides carnitine, ornithine, arginine, glutamine and lysine were taken up by the reconstituted liposomes with lower efficiency respect
to carnitine. Optimal activity was found at pH 8.0. The Km for carnitine on the external side of the transporter was 10.9±0.16 mM. The activation
energy of the carnitine transport derived by Arrhenius plot was 16.1 kJ/mol.
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Cytosolic acyl-CoA containing acyl-groups of different
lengths (from acetyl to long chain fatty acyl), are substrates for
several metabolic pathways in at least three different
organelles, i.e., mitochondria, peroxisomes and endoplasmic
reticulum. Since CoA pools are sequestered in the different
cellular compartments, the acyl-CoA is virtually transported
into the various sub-cellular locations by shuttle systems that
perform the translocation of the acyl unit as acyl-carnitine [1–Abbreviations: NEM, N-ethylmaleimide; NPheM, N-phenylmaleimide;
PheAsO, phenylarsine oxide; DTE, 1.4-dithioerythritol; PLP, pyridoxal 5-
phosphate; SITS, 4-acetamido-4′-isothiocyanato-2,2′-stilbenedisulfonic acid;
DIDS, 4,4′-diisothiocyanato-stilbene-2,2′-disulfonic acid; WRK, Woodward's
reagent K; EDC, 1-ethyl-3(3-dimethylaminopropyl)carbodiimmide; C12E8,
octaethylene glycol monododecyl ether; NDP40, Nonidet P40
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doi:10.1016/j.bbamem.2006.01.0043]. The shuttle systems need both transferase enzymes for the
transfer of the acyl-groups from the CoA to carnitine and vice
versa, and transport systems to enable the translocation of the
carnitine derivatives. The most well known of these systems,
the mitochondrial carnitine shuttle, consists of: (i) an
extramitochondrial carnitine acyl-transferase associated to the
outer mitochondrial membrane; (ii) a transmembrane carnitine/
acylcarnitine translocase, which is an integral inner membrane
protein, specific for carnitine and acylcarnitine that catalyzes
the antiport of carnitine and acylcarnitine and (iii) an
intramitochondrial carnitine acyl-transferase, associated with
the inner membrane and protruding into the mitochondrial
matrix [1–5]. A shuttle system must exist in peroxisomes
where long chain acyl groups are shortened to subsequently be
transferred to mitochondria for the complete oxidation; the
presence of acyltransferase and transport activities in peroxi-
somes support the existence of this metabolic process [1,6–9].
Enzymes that require acyl-CoA thioesters in the endoplasmic
reticulum include: an intralumenal oriented diacylglycerol acyl
transferase that is involved in triacylglycerol synthesis for the
VLDL production [10,11]; an internal acyl-CoA:cholesterol
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internal carnitine acetyltransferase and carnitine palmitoyltrans-
ferase for the acetylation of intralumenal compounds, fatty acid
elongation and other important functions [2,3,13,14]. Thus, as in
the other organelles, the endoplasmic reticulum carnitine, may
also play an important function in shuttling. Nevertheless, only
very recently, the existence of a transport system for carnitine has
been proposed on the basis of studies performed with intact
microsomes [15]. The transport properties described for this
transporter are different from those of the mitochondrial
transporter [5,16], being more similar to the feature of a pore.
The final proof of a protein mediated transport can be given by
the reconstitution of the transporter into liposomes. This
approach also allows the further characterization of the
membrane transport system at a functional level and represents
a methodology for testing the transport activity in purified
protein fractions for molecular studies. This type of methodo-
logical approach has been used for carnitine transporters both of
mitochondria and plasma membrane [16,17]. The present study
investigated a procedure of the reconstitution of the carnitine
transporter from solubilized rat liver microsomes into liposomes.
Most of the functional properties found in the reconstituted
system overlap with those described in intact microsomes, as
well as additional functional properties of this transporter have
been shown here.
2. Materials and methods
2.1. Materials
Amberlite Bio-Beads SM-2 was purchased from Bio-Rad, Sephadex G-50
and G-75 from Pharmacia, L-[3H]carnitine and other labelled compounds from
Amersham, L-α-phosphatidylcholine from fresh turkey egg yolk (EYPL) from
Fluka. All other reagents were of analytical grade.
2.2. Preparation of microsomes
Microsomes were prepared from male Wistar rats. Livers were homogenized
in an ice-cold medium containing 250 mM sucrose, 10 mM Tris, 1 mM EGTA
(pH 7.4). The homogenate was centrifuged at 500×g for 10 min; the supernatant
was then centrifuged at 10,000×g for 20 min; the resulting supernatant was
centrifuged at 20,000×g for 20 min; the resulting supernatant was ultracen-
trifuged at 100,000×g for 60 min. The pellet was resuspended in fresh medium
and centrifuged again at 100,000×g for 60 min. The microsomal pellet was then
resuspended and stored at −80 °C.
2.3. Reconstitution of the carnitine transporter
Aliquots of 50 μl frozen microsomes (1–1.5 mg protein) were solubilized
with 500 μl 1% Triton X-100 (without buffer and salts) and centrifuged for 10
min at 12,000×g. The protein extract was reconstituted into liposomes by the
cyclic detergent removal procedure [18,19]. In this procedure, the mixed
micelles containing detergent, protein and phospholipids were repeatedly passed
through a column filled with Bio-Beads SM-2 resin to remove the detergent. The
composition of the initial mixture used for reconstitution was: 50 μl of the
microsomal extract (about 35 μg protein in 1% Triton X-100), 85 μl of 10%
Triton X-114, 100 μl of liposomes (10 mg phospholipids, prepared as described
previously [19]), 20 mMHEPES pH 8.0 (except when differently specified) and,
when present, the internal substrate at the concentrations indicated in the figure
legends, in a final volume of 700 μl. After vortexing, this mixture was passed 12
times through the same Bio-Beads SM-2 column (0.5×3.0 cm) preequilibrated
with a buffer containing 20 mM HEPES pH 8.0. All the operations wereperformed at 4 °C, except the passages through Bio-Beads SM-2 column that
were performed at room temperature.
2.4. Transport measurements
550 μl of proteoliposomes were passed through a Sephadex G-75 column
(0.7×15 cm) preequilibrated with 20 mM NaCl and 10 mM HEPES (pH 8.0).
The first 600 μl of the turbid eluate from the Sephadex column were collected,
transferred to reaction vessels (100 μl each), and readily used for transport
measurements by the inhibitor stop method [20]. For uptake measurements,
transport was initiated by adding 0.1 mM [3H]carnitine. After the required time
interval, the reaction was stopped by adding 1 mM HgCl2; in control samples,
the inhibitor was added together with the labelled substrate at time zero. For
efflux measurements, the proteoliposomes were prelabelled by transporter-
mediated radioactivity equilibration before starting the transport assay. This was
achieved by incubating the proteoliposomes (600 μl), passed through Sephadex
G-75, with 10 mM [3H]carnitine with a specific radioactivity of 10 nCi/nmol, for
60 min at 25 °C. Then, the external radioactivity was removed by passing again
the proteoliposomes through Sephadex G-75 as described above. Transport was
started by adding external buffer or substrates at the concentration indicated in
the figure legends and stopped, at the appropriate time interval. The assay
temperature was 25 °C. Finally, each sample of proteoliposomes (100 μl) was
passed through a Sephadex G-50 column (0.6×8 cm) to separate the external
from the internal radioactivity. The liposomes eluted with 1.3 ml of 20 mMNaCl
were collected in 4 ml of scintillation mixture, vortexed and counted. For the
determination of the [3H]carnitine uptake, the experimental values were
corrected by subtracting the respective controls (samples inhibited at time
zero). For kinetic determinations, the initial transport rate was evaluated from
the radioactivity taken up by the proteoliposomes in 5 min, i.e., within the initial
linear range of the substrate uptake. Specific transport was referred to the
amount of protein in the proteoliposomes. In the efflux experiments the transport
activity was expressed as the residual intraliposomal cpm [19].
2.5. Other methods
The protein was determined by the Lowry method, modified for the presence
of non-ionic detergents [21].3. Results
3.1. Optimal conditions for reconstitution
The reconstitution procedure for the microsomal carnitine
transporter has been optimized by adjusting the parameters that
influence the efficiency of the solubilization of the transport
protein in active form and its incorporation into the liposomes,
i.e., the type and concentration of the detergent, the detergent/
lipid ratio, the protein concentration and the number of passages
through the same Bio-Beads SM-2 column [18,19]. In these
experiments, the [3H]carnitine uptake into the proteoliposomes
in 10 min, that is related to the specific activity of the
transporter, and the intraliposomal volume, that is related to the
efficiency of reconstitution, have been measured.
For the reconstitution procedure used here, the protein has to
be first solubilized in detergent and then mixed with
phospholipids and additional detergent to allow the formation
of proteoliposomes from mixed micelles (see Materials and
methods). Various detergents that are efficiently absorbed onto
Bio-Beads SM-2 were tested by using each of them both in the
solubilization and the reconstitution steps. Triton X-114 was
found to be the most effective; Triton X-100, C12E8, Triton N-
57 and NDP40 led to a final transport activity ranging from
Fig. 1. Dependence of the carnitine transport activity and proteoliposomal
volume on protein concentration. The reconstitution was performed as described
in Materials and methods except that the concentrations of protein in the
reconstitution mixture was varied as indicated. Transport was measured as 0.1
mM [3H]carnitine uptake into proteoliposomes, (●); internal volume of the
proteoliposomes, (○). Similar results were obtained in three different
experiments.
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(Table 1). Taking into account the results described above, the
effectiveness of adding a different detergent in the reconstitu-
tion step from that used for the solubilization was tested. It was
found that the activity of the transporter was improved by
solubilizing the microsomes with 1.0% Triton X-100 and
adding Triton X-114 in the reconstitution mixture. The transport
activity was optimal when the concentration of detergent in the
reconstitution was 12 mg/ml Triton X-114; under these
conditions the detergent/phospholipid ratio was 0.9 w/
w (Table 1). No salt or buffer was added in the solubilization
step, since these compounds reduced the extraction of the active
transport protein (not shown).
The transport increased almost linearly with the protein
concentration up to 40 μg/ml; above this value a saturation-like
behaviour was observed. The intraliposomal volume decreased
by increasing the protein concentration, indicating that higher
concentrations of protein cause the formation of less or smaller
liposomes (Fig. 1). The transport activity increased with the
number of column passages up to 8 and remained nearly
constant in the range from 8 to 18 passages; in this range the
intraliposomal volume was not critically influenced by the
number of columns passages (experiments not shown).Table 1
Effect of detergents in the solubilization and reconstitution of the carnitine
transporter
Detergent in
solubilization
(mg/ml)
Detergent in
reconstitution
(mg/ml)
Transport
(pmol/mg/
10 min)
Internal volume
(μl/mg phospholipid)
TX-100 10 TX-100 8.6 34.2 ± 6.0 4.2 ± 0.4
TX-100 12.0 56.0 ± 7.1 4.0 ± 0.4
TX-114 5.7 59.6 ± 8.2 4.2 ± 0.3
TX-114 8.6 144 ± 22 4.6 ± 0.4
TX-114 12.0 242 ± 36 4.5 ± 0.5
TX-114 15.7 212 ± 55 4.3 ± 0.4
TX-114 20.0 193 ± 26 4.1±0.3
TX-114 10 TX-114 8.6 109±4.8 3.9±0.4
TX-114 12.0 154±17 4.0±0.3
TX-100 8.6 47.5±7.6 4.1±0.4
TX-100 12.0 86.4±12 3.7±0.4
C12E8 10 C12E8 12.0 56.6±9.4 2.8±0.3
TX-100 12.0 39.6±5.4 3.1±0.3
TX-114 12.0 58.0±7.2 3.7±0.3
TN-57 10 TN 57 12.0 44.4±6.2 2.1±0.2
TX-100 12.0 47.0±7.4 2.7±0.3
TX-114 12.0 58.0±8.4 3.5±0.3
NDP40 10 NDP40 12.0 23.8±6.0 2.5±0.2
TX-100 12.0 30.2±5.8 2.6±0.3
TX-114 12.0 37.2±10 3.1±0.2
Microsomes were solubilized, with a buffer containing 1% of the indicated
detergent. The reconstitution was performed, as described in Materials and
methods, except that the different detergents at the indicated concentrations were
added. Transport and internal volume of the proteoliposomes was measured as
described in Materials and methods. The results are means±S.D. from three
experiments.
Abbreviation: T = Triton.According to the results described, a protein concentration of
about 50 μg/ml (corresponding to a protein/phospholipid ratio
of 0.005 w/w), which represents a good compromise between
optimal activity and internal volume, and 12 column passages
were used in the experiments.
Cardiolipin has been reported to be essential for the activity
of the mitochondrial carnitine carrier [22]. This phospholipid
did not exert any influence on the activity of the reconstituted
microsomal carnitine transporter upon addition to the solubi-
lization or the reconstitution at concentrations ranging from 20
to 200 μg/ml (not shown).
3.2. Functional characterization
To investigate the mode of transport (i.e., uniport or antiport)
of the reconstituted transporter, the time dependence of carnitine
uptake into proteoliposomes has been studied in the presence
and absence of internal substrate. To achieve this objective, 0.1
mM [3H]carnitine was added to proteoliposomes without
internal substrate or containing internal 15 mM carnitine or
acetylcarnitine. As shown in Fig. 2, the uptake of [3H]carnitine
into the proteoliposomes with or without internal carnitine or
acetylcarnitine was nearly the same, increasing with the time up
to the radioisotopic equilibrium that was reached after about 60
min. The data indicated that the transport process occurred by a
uniport mode. The transport was independent of the presence of
external or internal Na+ (not shown) excluding the occurrence
of co-transport. The experimental data describing the transport
of carnitine in the absence of intraliposomal substrate, fitted a
first order rate equation. The first order rate constant, k, was
0.068 min−1 (0.080±0.023 from 3 different experiments); the
transport rate (calculated as the product of k and the transport at
equilibrium) was 28 pmol×min−1 ×mg protein−1 (26±5 from 3
different experiments). The carnitine uptake was abolished by
the incubation of the proteoliposomes with trypsin. Furthermore
no carnitine uptake was detected into proteoliposomes
Fig. 2. Time course of [3H]carnitine uptake by reconstituted proteoliposomes.
0.1 mM [3H] carnitine was added at time zero to proteoliposomes containing 15
mM internal carnitine (▴), or 15 mM internal acetylcarnitine (▿) or without
internal substrate (▵). (□) 0.2 mg/ml trypsin was added to proteoliposomes
without internal substrate; (○) liposomes reconstituted without protein or (◼)
with boiled protein; the transport reaction was stopped at the indicated times, as
described in Materials and methods. Similar results were obtained in three
different experiments.
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indicated that the [3H]carnitine uptake observed was due to the
solubilized protein.
The effect, on the carnitine transport, of protein modifying
reagents that react with lysine (PLP, DIDS, SITS [23,24]),
cysteine (maleimides, mersalyl, HgCl2 PheAsO [25,26]),
arginine (methylglyoxal, phenylglyoxal [27]), and glutamate
or aspartate (WRK [28], EDC [24]) functional groups was
tested. As shown in Table 2, among the SH reagents, only
HgCl2 efficiently inhibited the transport leading to a suppres-
sion of about 80% of the activity at 0.5 mM concentration.
Among the reagents of other functional groups, PLP inhibitedTable 2
Effect of inhibitors on the reconstituted carnitine transport
Inhibitor Concentration (mM) Residual activity (%)
NEM 1 98±8
NPheM 1 103±12
mersalyl 1 95±11
HgCl2 0.5 21±8
PheAsO 1 96±9
methylglyoxal 5 98±5
phenylglyoxal 5 100±12
WRK 5 108±11
EDC 2 95±9
PLP 20 50±10
SITS 2 102±9
DIDS 1 30±8
Transport was measured as 0.1 mM [3H] carnitine uptake in 10 min into
proteoliposomes, reconstituted as described in Materials and methods. The
inhibitors were added 1 min before the labelled substrate at the concentrations
indicated. Percent of residual activity was calculated for each experiment with
respect to the control sample (without added inhibitor, referred as 100%). The
results are means±S.D. of the percentages for three experiments. The average
transport activity of the control samples of the three experiments analyzed was
279±67 pmol/10 min/mg protein.50% of the transport although only at considerably higher
concentrations and DIDS exerted a significant inhibition (70%)
at 1 mM concentration. All the other inhibitors had very low if
any effect. As HgCl2 was the most effective inhibitor, the
inhibition was further characterised. The dependence of the
inhibition on the concentration of HgCl2 was studied. The data
is reported in Fig. 3 A as a dose–response curve, from which an
IC50 of 0.17 mM (0.16±0.03 mM) for HgCl2 was calculated. In
order to verify whether HgCl2 reacted with Cys residues of the
protein, the effect of DTE on the inhibition was tested. As
expected (Fig. 3B), HgCl2 strongly reduced the uptake of
carnitine in the proteoliposomes. On the contrary, DTE had no
effect on the uptake. After 20 min the addition of DTE to the
proteoliposomes treated with HgCl2 rapidly and completely
reversed the inhibition, indicating that HgCl2 inhibited the
transporter by reacting with SH group(s) of Cys residues of the
protein.
The specificity of the transporter towards molecules that
have some structural homology with carnitine or that are known
to be transported through intracellular membranes likeFig. 3. Inhibition of the carnitine transporter by HgCl2 and reversal by DTE. (A),
dose response curve for the inhibition of the reconstituted carnitine transport by
HgCl2. Proteoliposomes were incubated with HgCl2 at the indicated concentra-
tions for 1 min. Then, carnitine transport was measured by adding 0.1 mM [3H]
carnitine and stopped after 5 min, as described in Materials and methods. (B)
Time course of [3H]carnitine uptake by reconstituted proteoliposomes (○) in the
absence or (●) in the presence of DTE, and in the presence of 0.5 mM HgCl2
(◼). In (▵) 3 mM DTE was added to an aliquot of proteoliposomes treated with
HgCl2.
Table 3
Specificity of the reconstituted transporter towards substrates
Labelled substrate Transport
(pmol/10 min/mg protein)
[3H] carnitine 270±42
[3H] ornithine 202±75
[3H] lysine 150±42
[3H] arginine 177±21
[3H] glutamine 195±21
[14C] glutamate 77±52
[14C] malate 42±27
[14C] citrate 47±31
[32P] ATP 30±22
Transport was measured as uptake of 0.1 mM of the indicated labelled substrates
in 10 min into proteoliposomes, reconstituted as described in Materials and
methods. The results are means±S.D. from three experiments.
Fig. 5. Arrhenius plot of the temperature dependence of the reconstituted
carnitine transport activity. 0.1 mM [3H] carnitine was added to proteoliposomes
incubated at the indicated temperature. The transport activity (v) is expressed as
pmol/min/mg protein. Similar results were obtained in two different
experiments.
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were tested. To investigate this further, the transport of different
labelled substrates was determined in proteoliposomes recon-
stituted with the microsomal extract under the condition of
optimal carnitine transport activity. As shown in Table 3,
besides carnitine, which was the most efficiently transported
substrate, also ornithine, glutamine, arginine, lysine were
transported by the reconstituted protein, however with a lower
efficiency. On the contrary, glutamate, malate, citrate and ATP
showed a very low transport activity.
The dependence of the transport rate on the carnitine
concentration was studied (Fig. 4). The data fitted the
Michaelis–Menten equation from which a Km of 11.7 mM
(10.9±0.16 mM from 5 exp.) and a Vmax of 0.77 nmol/min/mg
protein (0.70±0.26 nmol/min/mg from 5 exp.) was extrapolat-
ed. The relatively high standard deviation often associated with
the rate values is due to variations in the amount of active
transport protein molecules present in the different preparations.
The dependence of the transport rate on the temperature was
studied. The Arrhenius plot of the experimental data (Fig. 5)
showed a linear dependence in the range 10–32 °C. From theFig. 4. Dependence on substrate concentration of the rate of carnitine transport.
[3H] carnitine at the indicated concentration was added to proteoliposomes. The
transport rate was measured, as described in Materials and methods as uptake in
5 min. Data were plotted according to Michaelis–Menten. Similar results were
obtained in five different experiments.slope of the straight line, an activation energy of 16.1 kJ/mol
was calculated. Unexpectedly, the transport rate increased at
temperatures below 10 °C (not shown).
The dependence of the transport activity on the pH was also
studied. Fig. 6 shows the dependence of the initial rate and the
transport at the equilibrium in a range of pH between pH 6.5 and
pH 9.0. The maximal activity was measured at pH 8.0. A sharp
decrease of transport was observed at a lower pH, whereas a less
dramatic decrease was detected at a more alkaline pH in respect
to pH 8.0. Similar patterns were observed both at transport rate
and equilibrium transport indicating that the pH may influence
both the activity of the transport protein and the amount of
transporter inserted into the liposomes.
To verify whether the reconstituted transporter could also
catalyze a carnitine flux from inside to outside the proteolipo-
somes, the carnitine efflux was determined. To this aim, theFig. 6. Effect of pH on the reconstituted carnitine transporter. All the
experimental procedures from the reconstitution to the transport measurement
(see Materials and methods) were performed in 20 mMHEPES/Tris buffer at the
indicated pH. Transport rate was measured as 0.1 mM [3H] carnitine uptake in 5
min (○) or 60 min (●) into proteoliposomes. Similar results were obtained in
three different experiments.
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process (see Materials and methods) that allows the accumu-
lation of radioactivity only into the active proteoliposomes, i.e.,
vesicles containing active transporter molecules in the mem-
brane. Furthermore, by this procedure, it was also possible to
check whether longer chain acylcarnitine could stimulate the
carnitine counter-transport. In fact, this type of experiment was
not allowed with long chain acylcarnitine inside the vesicles,
since these molecules exert a detergent effect [31]. Fig. 7 shows
that the labelled carnitine effluxed from the reconstituted
vesicles. The efflux was virtually abolished by the addition of
HgCl2 to the proteoliposomes; nearly no inhibition was
observed upon addition of mersalyl (not shown). The addition
of 10 mM carnitine, 10 mM acetylcarnitine, 10 mM
propionylcarnitine (not shown), 10 mM ornithine (not
shown), 2.5 mM pentanoylcarnitine or 2 mM octanolylcarni-
tine, to the external side of the vesicles, did not exert any effect
on the basic efflux. On the contrary, the addition of 0.5 mM
stearoylcarnitine or 0.5 mM palmitoylcarnitine, that could not
be used at higher concentrations due to their detergent property,
stimulated the carnitine efflux. The finding that both the uptake
(prelabelling; see Materials and methods) and the efflux
processes occurred in the same active proteoliposome pool
and were inhibited by HgCl2, indicated that they were mediated
by the same transporter.
4. Discussion
A definitive proof of the existence of a membrane transporter
can be given by its functional reconstitution into artificial
membrane. The reconstitution system leads to further advan-
tages in the functional characterization of a transporter, with
respect to intact cells or sub-cellular membrane vesicles, such as
the possibility to control the experimental conditions in the
internal compartment; the reduction of interferences due to theFig. 7. Dependence of [3H] carnitine efflux from proteoliposomes on external
carnitine derivatives. Efflux of 15 mM [3H] carnitine was measured in the
presence of external 10 mMHEPES pH 8, 20 mMNaCl: (○) no addition, (●) 10
mMcarnitine, (▵) 10mMacetylcarnitine, (◼) 2.5mMpentanoylcarnitine, (□) 2
mM octanoylcarnitine, (▿) 0.5 mM palmitoylcarnitine (▴) 0.5 mM stearoylcar-
nitine, (x) 0.5 mM HgCl2 and (⋄) 0.5 mM palmitoylcarnitine plus 0.5 mM
HgCl2. Similar results were obtained in three different experiments in which the
initial intraliposomal radioactivity ranged from about 3800 to 5600 cpm.virtual absence of external and internal enzymes; a longer
radioactivity equilibration time with respect to native membrane
vesicles, due to the low protein/lipid ratio (less that one protein
per liposome), which leads to a better kinetic resolution and the
possibility of modifying the lipid composition of the membrane.
In this paper, the existence of the carnitine transporter of the
endoplasmic reticulum, previously proposed on the basis of
studies in intact microsomes [15], has been confirmed by its
reconstitution into liposomes. We have adopted a reconstitution
procedure successfully used for the characterization of
mitochondrial and plasma membrane transport systems
[17,19,32] among which are the mitochondrial and the plasma
membrane (OCTN2) carnitine transporters [16,17]. This
reconstitution method leads to the formation of proteoliposomes
larger than those obtained by other methods like the freeze–
thaw sonication [19] thus increasing the accumulation of
radioactivity inside the active vesicles, i.e., the proteoliposomes
containing active transporters inserted into the membrane. The
reconstitution has been optimized by adjusting the critical
factors influencing the formation of the proteoliposomes, i.e.,
the type and concentration of detergent, the detergent/
phospholipid ratio, the protein/phospholipid ratio and the
number of passages through the Bio-Beads SM-2 column.
Differently from the reconstitution of other carnitine transpor-
ters carried out by this procedure [16,17], the optimal condition
for the reconstitution of the endoplasmic reticulum carnitine
transporter has been achieved by using different detergents in
the solubilization and reconstitution steps. This difference in the
reconstitution parameters reflects the different functional
properties of this transporter with respect to the mitochondrial
and plasma membrane carnitine transport systems (see below).
To our knowledge, the reconstitution of the carnitine transporter
represents one of the few cases of reconstitution of transport
systems of the endoplasmic reticulum. The sulfate transporter
was reconstituted by freeze–thaw sonication [33]; the ATP
transporter was reconstituted by a procedure based on detergent
dilution [29]. Very recently a transporter for mannosylpho-
sphoryldolichol analogues and the GDP-mannose transporter
have been reconstituted by a dialysis procedure [34] and by
detergent removal/freeze–thaw sonication [35] respectively.
The reconstitution of the carnitine transport activity
described here indicates the occurrence of a protein mediated
process, that is confirmed by the following findings: the
treatment of the proteoliposomes with trypsin and boiling
abolish the transport of carnitine; reagents that specifically react
with Cys (HgCl2) and Lys (PLP and DIDS) residues, inhibit the
carnitine uptake. On the one hand, the inhibition exerted by
DIDS seems to be a common property of endoplasmic reticulum
transport systems [29,33–37]. On the other hand, it has been
found that the inhibition caused by HgCl2 is a specific property
of the carnitine transporter; thus, it has been investigated further.
The inhibition by HgCl2 is due to its reaction with one or more
Cys residues of the protein as was confirmed by the fast reversal
when DTE was added. The finding that other SH reagents like
mersalyl or NEM fail to inhibit the transport, suggests that the
critical Cys residues must be located in a small hydrophilic
pocket of the protein that can be reached by HgCl2 (ranging in
130 A. Tonazzi et al. / Biochimica et Biophysica Acta 1758 (2006) 124–131size from 1 Å of the Hg++ to 2.4 Å of the HgCl2 [38]) and not by
other larger compounds. It can also be hypothesized that two
close SH residues must be cross-linked to inhibit the transport;
accordingly, HgCl2, differently from NEM or mersalyl, can
simultaneously bind two vicinal SH residues [26].
The mode of transport of the reconstituted carnitine
transporter is of the uniport type. However it was found that
the externally added long chain carnitine derivatives specifi-
cally stimulate the efflux of carnitine from the proteoliposomes.
The most probable interpretation of this result is that the same
transporter that catalyses the uniport of carnitine may behave as
an antiporter carnitine/long chain acylcarnitine. This is in
agreement with the function of the carnitine shuttle in the
endoplasmic reticulum in which the transfer of cytosolic long
chain acyl-CoA is essential for the diacylglycerol synthesis used
to assemble the VLDL. The antiport may also function the other
way round, i.e., carnitine from inside to outside the proteolipo-
somes and acylcarnitine in the opposite direction. However, this
condition could not be experimentally tested, since the long
chain acylcarnitines exerted a strong detergent effect when they
were inserted inside the vesicles during the reconstitution
procedure. Additionally, the carnitine uniport should play the
function of equilibrating the endoplasmic reticulum and the
cytosolic carnitine concentration. The property to catalyze both
antiport and uniport of substrates has been previously described
for the mitochondrial carnitine/acylcarnitine transporter [39],
even though with some differences with respect to the
endoplasmic reticulum transporter. Furthermore, the ability to
catalyze both uniport and antiport of substrates may explain the
previous results obtained in intact microsome studies [15]. The
carnitine transporter of the endoplasmic reticulum shows
specificity towards substrates that share the presence of positive
and negative charges in the molecule; whereas negatively
charged substrates are transported with a very low efficiency or
are not transported. Thus, the carnitine transporter may also
function as an amino acid transporter, as was found for the yeast
plasma membrane carnitine transporter Agp2p [9,40]. In the
reconstituted system it was determined the Km of the
transporter for carnitine; its value is higher than the carnitine
concentration in the cell and it is of the same range of Km as the
transporter for mannosylphosphoryldolichol [34]. There is no
experimental evidence to assess if the transporter has inserted
into the proteoliposomes in the native orientation. Since several
transport systems reconstituted by the cyclic detergent removal
procedure, that has been used in this study, showed a right side
out orientation [17–19,30,32], it is very likely that the
endoplasmic reticulum carnitine transporter also inserted in a
similar way. Thus, the Km measured in the proteoliposomes
should correspond to the extralumenal Km. The activation
energy measured for the reconstituted transporter is lower than
that of the carriers [16]. Thus, the endoplasmic carnitine
transporter seems to share carrier and channel properties as well.
From a functional point of view, the carnitine transporter of the
endoplasmic reticulum is quite different from the carnitine
transporters of mitochondria and plasma membrane (OCTN2).
On the one hand, the transporter described in this paper, shows
different sensitivity to inhibitors, a low affinity for carnitine, alack of dependence on cardiolipin and a low activation energy
that unequivocally distinguishes it from the mitochondrial ones
[16]. On the other hand the OCTN2 transporter is clearly
distinguished from the endoplasmic reticulum transporter by the
obligatory antiport mode of transport, the sodium dependence,
the very different affinity for carnitine and the pH dependence
[17,41]. On the basis of these observations it may be
hypothesized that the endoplasmic reticulum carnitine trans-
porter does not belong either to the mitochondrial carrier family
or to the OCTN sub-family of the plasma membrane. At this
stage it cannot be said whether the endoplasmic reticulum
carnitine transporter belongs to a known protein family or it is a
single protein member as was found, for example, in the case of
the CorA magnesium transport system [42]. This last possibility
has to be taken into account in view of the peculiar functional
properties of the transport system described here. A screening of
the protein databases revealed the existence of sequences with
unknown functions that show some percentage of endoplasmic
reticulum localization, as analyzed by the PSORT software.
However, the identity of these sequences with proteins involved
in carnitine transport and metabolism, found by global and local
alignment analysis, did not give significant indications to
identify the hypothetical sequence of the carnitine transporter.
However, it seems very likely that there are still enough
unidentified protein sequences and most likely untranslated
genes that may be the focus for further studies into the
identification of the molecular counterpart of the endoplasmic
reticulum carnitine transporter.
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